Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults
Launched by UNIVERSITY OF PITTSBURGH · Nov 27, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of therapies designed to help young people with Autism Spectrum Disorder (ASD) manage their emotions better. Researchers want to find out if one therapy, which is specifically created for autistic individuals, is more effective than a general one. The goal is to improve emotional regulation, which can lead to better mental health overall. The trial is taking place in community settings, meaning it will be accessible to participants in their local areas through partnering organizations.
To participate in this study, individuals must have a professional diagnosis of autism and show signs of emotional challenges. They should be able to communicate in some way, whether verbally or nonverbally. Participants must also live in Alabama or Pennsylvania and have an adult caregiver who can help with assessments. However, those experiencing severe mental health crises, such as acute psychosis or thoughts of harming themselves or others, are not eligible. If you or someone you know is interested in this study, it could be a valuable opportunity to receive specialized support for emotional challenges while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • professional diagnosis of ASD
- • a score in the clinical range on the EDI-Reactivity or EDI-Dysphoria scale based on caregiver report or self-report
- • The study is open to people with a range of communication abilities. Participants must be able to consent to the study themselves and answer questions about themselves.
- • Participants need to have a support person that could answer questions about them too. This could be a parent, caregiver, family member, partner or friend.
- • Participants must live in Alabama or Pennsylvania.
- Exclusion Criteria:
- • - Higher level of care is needed (Imminent Suicide / Homicide Threat, acute psychosis, mania)
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Tuscaloosa, Alabama, United States
Patients applied
Trial Officials
Carla Mazefsky, PhD
Principal Investigator
University of Pittsburgh
Susan White, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported